When you hear the words Alzheimer's disease, what do you think of? The truth is, the picture most of us have of the disease is incomplete. Alzheimer's disease doesn't start when someone starts to lose their memory. It actually starts years ā sometimes decades ā earlier. The Rethinking Alzheimer's Disease Podcast is an engaging, narrative-style podcast miniseries for those curious or motivated to learn about Alzheimerās disease. Perhaps you have a family member with Alzheimerās disease, or ca ...
…
continue reading
MP4•Episode home
Manage episode 513815944 series 2740117
Content provided by MasterMedFacts LLC and RR Baliga MD. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by MasterMedFacts LLC and RR Baliga MD or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.
šØ Real-World vs RCT? Only 1 in 3 patients with AMI-related cardiogenic shock in Japan met the š¬ DanGer trial criteria for Impella use. The J-PVAD registry (šÆšµ, n=3975) reveals a stark āļø reality: eligibility matters, and survival varies!
š« Time to align practice with precision.
š Read the full European Heart Journal study for clinical pearls and caveats. #Impella #CardiogenicShock #DanGer #JPVAD #EHJ #MCS #RCTvsRealWorld
731 episodes